ESP Block in MIS Lumbar Spine Surgery
Erector Spinae Plane Block in Patients Undergoing Minimally Invasive Lumbar Spine Surgery: A Randomized Controlled Trial
Hospital for Special Surgery, New York
48 participants
May 15, 2023
INTERVENTIONAL
Conditions
Summary
This is a prospective, randomized controlled trial of patients undergoing minimally invasive transforaminal lumbar interbody fusion. This study will randomize patients into one of two groups: erector spinae plane (ESP) block and no ESP block.
Eligibility
Inclusion Criteria3
- Age 18-80
- Patients scheduled for MIS TLIF (any level) with the principal investigator
- ASA 1, 2, 3
Exclusion Criteria9
- ASA 4 or higher
- BMI >40
- Chronic opioid use (daily use for > 3 months)
- Revision surgery, any history of previous lumbar spine surgery
- Allergy to any of the study medications
- Non-English speaking
- Chronic renal insufficiency or failure (creatinine >2) or severe hepatic disease (cirrhosis, failure)
- Pregnancy
- Any concomitant surgery
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
ESP block is an opioid-sparing regional anesthetic involving bupivacaine and dexamethasone for lumbar spinal surgery with touted benefits including opioid use reduction and improved pain control.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05856539